Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)

by Valdés A,María del Pilar, Schroeder H,Francisca, Roizen G,Vicky, Honeyman M,Juan, Sánchez M,Leonardo
Published 2006

Pseudotumor cerebri como una manifestación excepcional de la enfermedad de Behçet: Caso clínico

by DURÁN,JOSEFINA, JURADO,MARISOL, JACOBELLI,SERGIO, EYMIN,GONZALO, CASTIGLIONE,ENZO, VALENZUELA,RAÚL, GUTIÉRREZ,MIGUEL A
Published 2010

Eficacia del infliximab en pacientes con síndrome de Behçet portadores de úveo-retinitis grave

by Merino,Guillermo, Varas,Gonzalo, Díaz,Gonzalo, Gutiérrez,Miguel, Massardo,Loreto, Pacheco,Daniel, Villarroel,Francisco, Cuchacovich,Miguel
Published 2006

Evaluación del tratamiento con infliximab en enfermos con artritis inflamatoria refractaria a drogas habituales

by Labarca S,Cristián, Massardo V,Loreto, García M,Paula I, Jacobelli G,Sergio
Published 2003

Terapia de inducción acelerada con infliximab en paciente con colitis ulcerosa grave refractaria a corticoides. Caso clínico

by Fluxá,Daniela, Flores,Lilian, Kronberg,Udo, Moreno,Mauricio, Figueroa,Carolina, Ibáñez,Patricio, Lubascher,Jaime, Simian,Daniela, Quera,Rodrigo
Published 2017

PIODERMA GANGRENOSO GIGANTE DE CURSO FULMINANTE ASOCIADO A ENFERMEDAD INFLAMATORIA INTESTINAL

by Bannura C,Guillermo, Barrera E,Alejandro, Melo L,Carlos
Published 2014

Rol de infliximab en enfermedad inflamatoria intestinal: Experiencia local

by Simian,Daniela, Quijada,María Isabel, Lubascher,Jaime, Acuña,Raúl, Quera,Rodrigo
Published 2013

Utilidad de la monitorización terapéutica de infliximab en el manejo de la enfermedad inflamatoria intestinal

by Quera,Rodrigo, Moreno,Mauricio, Simian,Daniela, Ibáñez,Patricio, Lubascher,Jaime, Figueroa,Carolina, Flores,Lilian, Kronberg,Udo, Pizarro,Gonzalo, Fluxá,Daniela
Published 2018

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

by Salehzadeh F, Mohammadikebar Y, Enteshary A, Ghanbarpour O, Mirzarahimi M
Published 2019

Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar

by Gellona V,José, Zarraonandia A,Antón, Zúñiga D,Alvaro, Palma C,Renato, Contreras P,Jaime, Silva Ch,Jaime, González D,Róbinson, Quintana V,Carlos
Published 2006

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease

by Byron P. Vaughn
Published 2021

Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study

by Mohammad Shehab, Mohamed Abu-Farha, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Jehad Abubaker, Fahd Almulla
Published 2021

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease

by Katsuyama A, Kusuhara S, Nishisho R, Matsumiya W, Azumi A, Nakamura M
Published 2019

Tumor inflamatorio miofibroblástico peritoneal. Respuesta favorable asociada a infliximab: Caso clínico

by Grünholz,Daniela, Appiani,Franco, Abarca,Constanza, Manríquez,María, Pinilla,Jorge, Wainstein,Eduardo
Published 2015

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease

by Matsumoto S, Mashima H
Published 2018

Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study

by Pedersen L, Szecsi PB, Johansen PB, Bjerrum PJ
Published 2020

Pathogenetic role of tumor necrosis factor (TNF-α) for the development of peritoneal tuberculosis in an experiment

by D. V. Plotkin, T. I. Vinogradova, M. N. Reshetnikov, Yu. R. Zyuzya, S. V. Okovityi, M. V. Sinitsyn, V. R. Gaitukaev, G. V. Rodoman, E. M. Bogorodskaya, P. K. Yablonskiy
Published 2021

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction

by Youlian Zhou, Zhenjiang Zech Xu, Yan He, Yunsheng Yang, Le Liu, Qianyun Lin, Yuqiang Nie, Mingsong Li, Fachao Zhi, Side Liu, Amnon Amir, Antonio González, Anupriya Tripathi, Minhu Chen, Gary D. Wu, Rob Knight, Hongwei Zhou, Ye Chen
Published 2018

Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature

by Kołt-Kamińska M, Żychowska M, Reich A
Published 2021

Systematic review of immunomodulatory therapies for hidradenitis suppurativa

by Lim SYD, Oon HH
Published 2019